Works matching IS 22351795 AND DT 2023 AND VI 12

Results: 64
    1
    2

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 1, doi. 10.1159/000535679
    Publication type:
    Article
    3

    Contents.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 605, doi. 10.1159/000535164
    Publication type:
    Article
    4

    Acknowledgment to Reviewers.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 603, doi. 10.1159/000534661
    Publication type:
    Article
    5
    6

    Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 510, doi. 10.1159/000533166
    By:
    • Vogel, Arndt;
    • Finn, Richard S.;
    • Blanchet Zumofen, Marie-Hélène;
    • Heuser, Carolina;
    • Sanchez Alvarez, Javier;
    • Leibfried, Michael;
    • Mitchell, Catherine R.;
    • Batson, Sarah;
    • Redhead, Gabrielle;
    • Gaillard, Vincent E.;
    • Kudo, Masatoshi
    Publication type:
    Article
    7
    8
    9

    Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Kariyama, Kazuya;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Naganuma, Atsushi;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Ohama, Hideko;
    • Tada, Fujimasa;
    • Nouso, Kazuhiro
    Publication type:
    Article
    10
    11
    12
    13

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 1, doi. 10.1159/000534621
    Publication type:
    Article
    14
    15

    Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 405, doi. 10.1159/000530495
    By:
    • Zhou, Jian;
    • Sun, Huichuan;
    • Wang, Zheng;
    • Cong, Wenming;
    • Zeng, Mengsu;
    • Zhou, Weiping;
    • Bie, Ping;
    • Liu, Lianxin;
    • Wen, Tianfu;
    • Kuang, Ming;
    • Han, Guohong;
    • Yan, ZhiPing;
    • Wang, Maoqiang;
    • Liu, Ruibao;
    • Lu, Ligong;
    • Ren, Zhenggang;
    • Zeng, ZhaoChong;
    • Liang, Ping;
    • Liang, Changhong;
    • Chen, Min
    Publication type:
    Article
    16
    17
    18

    Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 445, doi. 10.1159/000529824
    By:
    • Tan, Darren Jun Hao;
    • Tang, Ansel Shao Pin;
    • Lim, Wen Hui;
    • Ng, Cheng Han;
    • Nah, Benjamin;
    • Fu, Clarissa;
    • Xiao, Jieling;
    • Koh, Benjamin;
    • Tay, Phoebe Wen Lin;
    • Tan, Eunice X;
    • Teng, Margaret;
    • Syn, Nicholas;
    • Muthiah, Mark D;
    • Tamaki, Nobuharu;
    • Lee, Sung Won;
    • Kim, Beom Kyung;
    • Yau, Thomas;
    • Vogel, Arndt;
    • Loomba, Rohit;
    • Huang, Daniel Q.
    Publication type:
    Article
    19
    20
    21

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 288, doi. 10.1159/000534256
    Publication type:
    Article
    22
    23

    Erratum.

    Published in:
    2023
    Publication type:
    Correction Notice
    24

    Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
    By:
    • Merle, Philippe;
    • Kudo, Masatoshi;
    • Edeline, Julien;
    • Bouattour, Mohamed;
    • Cheng, Ann-Lii;
    • Chan, Stephen Lam;
    • Yau, Thomas;
    • Garrido, Marcelo;
    • Knox, Jennifer;
    • Daniele, Bruno;
    • Breder, Valeriy;
    • Lim, Ho Yeong;
    • Ogasawara, Sadahisa;
    • Cattan, Stéphane;
    • Chao, Yee;
    • Siegel, Abby B.;
    • Martinez-Forero, Iván;
    • Wei, Ziwen;
    • Liu, Chih-Chin;
    • Finn, Richard S.
    Publication type:
    Article
    25

    Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 339, doi. 10.1159/000529608
    By:
    • Monin, Malte Benedikt;
    • Baier, Leona I.;
    • Gorny, Jens G.;
    • Berger, Moritz;
    • Zhou, Taotao;
    • Mahn, Robert;
    • Sadeghlar, Farsaneh;
    • Möhring, Christian;
    • Boesecke, Christoph;
    • van Bremen, Kathrin;
    • Rockstroh, Jürgen K.;
    • Strassburg, Christian P.;
    • Eis-Hübinger, Anna-Maria;
    • Schmid, Matthias;
    • Gonzalez-Carmona, Maria A.
    Publication type:
    Article
    26

    Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 321, doi. 10.1159/000529574
    By:
    • Kudo, Masatoshi;
    • Aoki, Tomoko;
    • Ueshima, Kazuomi;
    • Tsuchiya, Kaoru;
    • Morita, Masahiro;
    • Chishina, Hirokazu;
    • Takita, Masahiro;
    • Hagiwara, Satoru;
    • Minami, Yasunori;
    • Ida, Hiroshi;
    • Nishida, Naoshi;
    • Ogawa, Chikara;
    • Tomonari, Tetsu;
    • Nakamura, Noriaki;
    • Kuroda, Hidekatsu;
    • Takebe, Atsushi;
    • Takeyama, Yoshifumi;
    • Hidaka, Masaaki;
    • Eguchi, Susumu;
    • Chan, Stephen L
    Publication type:
    Article
    27
    28

    Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 297, doi. 10.1159/000528537
    By:
    • Sekino, Yuta;
    • Tateishi, Ryosuke;
    • Fukumitsu, Nobuyoshi;
    • Okumura, Toshiyuki;
    • Maruo, Kazushi;
    • Iizumi, Takashi;
    • Numajiri, Haruko;
    • Mizumoto, Masashi;
    • Minami, Tatsuya;
    • Nakagomi, Ryo;
    • Sato, Masaya;
    • Asaoka, Yoshinari;
    • Nakagawa, Hayato;
    • Hayata, Yuki;
    • Fujiwara, Naoto;
    • Shiina, Shuichiro;
    • Koike, Kazuhiko;
    • Sakurai, Hideyuki
    Publication type:
    Article
    29
    30

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 1, doi. 10.1159/000533455
    Publication type:
    Article
    31
    32
    33

    Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 198, doi. 10.1159/000530134
    By:
    • De, Brian;
    • Upadhyay, Rituraj;
    • Liao, Kaiping;
    • Kumala, Tiffany;
    • Shi, Christopher;
    • Dodoo, Grace;
    • Abi Jaoude, Joseph;
    • Corrigan, Kelsey L.;
    • Manzar, Gohar S.;
    • Marqueen, Kathryn E.;
    • Bernard, Vincent;
    • Lee, Sunyoung S;
    • Raghav, Kanwal P.S.;
    • Vauthey, Jean-Nicolas;
    • Tzeng, Ching-Wei;
    • Tran Cao, Hop S.;
    • Lee, Grace;
    • Wo, Jennifer;
    • Hong, Theodore S;
    • Crane, Christopher H
    Publication type:
    Article
    34
    35
    36

    Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 229, doi. 10.1159/000528356
    By:
    • Wu, Jia-Yi;
    • Zhang, Zhi-Bo;
    • Zhou, Jian-Yin;
    • Ke, Jing-Peng;
    • Bai, Yan-Nan;
    • Chen, Yu-Feng;
    • Wu, Jun-Yi;
    • Zhou, Song-Qiang;
    • Wang, Shuang-Jia;
    • Zeng, Zhen-Xin;
    • Li, Yi-Nan;
    • Qiu, Fu-Nan;
    • Li, Bin;
    • Yan, Mao-Lin
    Publication type:
    Article
    37

    IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 238, doi. 10.1159/000528272
    By:
    • Kudo, Masatoshi;
    • Finn, Richard S.;
    • Galle, Peter R.;
    • Zhu, Andrew X.;
    • Ducreux, Michel;
    • Cheng, Ann-Lii;
    • Ikeda, Masafumi;
    • Tsuchiya, Kaoru;
    • Aoki, Ken-ichi;
    • Jia, Jing;
    • Lencioni, Riccardo
    Publication type:
    Article
    38

    Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
    By:
    • Ando, Yuwa;
    • Kawaoka, Tomokazu;
    • Kosaka, Masanari;
    • Shirane, Yuki;
    • Johira, Yusuke;
    • Miura, Ryoichi;
    • Murakami, Serami;
    • Yano, Shigeki;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atushi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Okamoto, Wataru;
    • Takahashi, Shoichi
    Publication type:
    Article
    39

    Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 262, doi. 10.1159/000528034
    By:
    • Xu, Bin;
    • Dong, San-Yuan;
    • Bai, Xue-Li;
    • Song, Tian-Qiang;
    • Zhang, Bo-Heng;
    • Zhou, Le-Du;
    • Chen, Yong-Jun;
    • Zeng, Zhi-Ming;
    • Wang, Kui;
    • Zhao, Hai-Tao;
    • Lu, Na;
    • Zhang, Wei;
    • Li, Xu-Bin;
    • Zheng, Su-Su;
    • Long, Guo;
    • Yang, Yu-Chen;
    • Huang, Hua-Sheng;
    • Huang, Lan-Qing;
    • Wang, Yun-Chao;
    • Liang, Fei
    Publication type:
    Article
    40
    41

    APPLE News.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000530731
    Publication type:
    Article
    42
    43
    44
    45

    Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    46
    47

    Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527759
    By:
    • Hosoda, Shunichi;
    • Suda, Goki;
    • Sho, Takuya;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Yang, Zijian;
    • Yoshida, Sonoe;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken
    Publication type:
    Article
    48
    49
    50

    PD-1/CTLA-4 Blockade Leads to Expansion of CD8<sup>+</sup>PD-1<sup>int</sup> TILs and Results in Tumor Remission in Experimental Liver Cancer.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000526899
    By:
    • Bufe, Sandra;
    • Zimmermann, Artur;
    • Ravens, Sarina;
    • Prinz, Immo;
    • Buitrago-Molina, Laura Elisa;
    • Geffers, Robert;
    • Woller, Norman;
    • Kühnel, Florian;
    • Talbot, Steven R.;
    • Noyan, Fatih;
    • Manns, Michael Peter;
    • Wedemeyer, Heiner;
    • Hardtke-Wolenski, Matthias;
    • Jaeckel, Elmar;
    • Davalos-Misslitz, Ana C.
    Publication type:
    Article